Загрузка...
Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results
BACKGROUND: Capecitabine, an orally administered fluoropyrimidines, is widely used in the treatment of multiple malignancies. It has been extensively evaluated in patients with gastroesophageal carcinoma. Since recent reviews have discussed phase I/II trials (Cancer 107:221–231, 2006; Drugs 67:601–6...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2503649/ https://ncbi.nlm.nih.gov/pubmed/18728703 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|